A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol

Abstract Background Anthracyclines and monoclonal antibodies against human epidermal growth factor receptor-2 (HER2) are frequently used to treat breast cancer but they are associated with risk of developing cardiotoxicity. Implementation of cardioprotective strategies as part of breast cancer treat...

Full description

Bibliographic Details
Main Authors: Estíbaliz Díaz-Balboa, Violeta González-Salvado, Beatriz Rodríguez-Romero, Amparo Martínez-Monzonís, Milagros Pedreira-Pérez, Patricia Palacios-Ozores, Rafael López-López, Carlos Peña-Gil, José R. González-Juanatey
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-021-01970-2
_version_ 1818849783825039360
author Estíbaliz Díaz-Balboa
Violeta González-Salvado
Beatriz Rodríguez-Romero
Amparo Martínez-Monzonís
Milagros Pedreira-Pérez
Patricia Palacios-Ozores
Rafael López-López
Carlos Peña-Gil
José R. González-Juanatey
author_facet Estíbaliz Díaz-Balboa
Violeta González-Salvado
Beatriz Rodríguez-Romero
Amparo Martínez-Monzonís
Milagros Pedreira-Pérez
Patricia Palacios-Ozores
Rafael López-López
Carlos Peña-Gil
José R. González-Juanatey
author_sort Estíbaliz Díaz-Balboa
collection DOAJ
description Abstract Background Anthracyclines and monoclonal antibodies against human epidermal growth factor receptor-2 (HER2) are frequently used to treat breast cancer but they are associated with risk of developing cardiotoxicity. Implementation of cardioprotective strategies as part of breast cancer treatment are needed. To date, a limited number of studies have examined the effectiveness of cardiac rehabilitation programs or exercise programs in the prevention of cardiotoxicity through an integral assessment of cardiac function. The ONCORE study proposes an exercise-based cardiac rehabilitation program as a non-pharmacological tool for the management of chemotherapy-induced cardiotoxicity. Methods The study protocol describes a prospective, randomized controlled trial aimed to determine whether an intervention through an exercise-based CR program can effectively prevent cardiotoxicity induced by anthracyclines and/or anti-HER2 antibodies in women with breast cancer. Three hundred and forty women with breast cancer at early stages scheduled to receive cardiotoxic chemotherapy will be randomly assigned (1:1) to participation in an exercise-based CR program (intervention group) or to usual care and physical activity recommendation (control group). Primary outcomes include changes in left ventricular ejection fraction and global longitudinal strain as markers of cardiac dysfunction assessed by transthoracic echocardiography. Secondary outcomes comprise levels of cardiovascular biomarkers and cardiopulmonary function through peak oxygen uptake determination, physical performance and psychosocial status. Supervised exercise program-related outcomes including safety, adherence/compliance, expectations and physical exercise in- and out-of-hospital are studied as exploratory outcomes. Transthoracic echocardiography, clinical test and questionnaires will be performed at the beginning and two weeks after completion of chemotherapy. Discussion The growing incidence of breast cancer and the risk of cardiotoxicity derived from cancer treatments demand adjuvant cardioprotective strategies. The proposed study may determine if an exercise-based CR program is effective in minimizing chemotherapy-induced cardiotoxicity in this population of women with early-stage breast cancer. The proposed research question is concrete, with relevant clinical implications, transferable to clinical practice and achievable with low risk. Trial registration ClinicalTrials.gov Identifier: NCT03964142. Registered on 28 May 2019. Retrospectively registered. https://clinicaltrials.gov/ct2/show/NCT03964142
first_indexed 2024-12-19T06:38:44Z
format Article
id doaj.art-c2e13b96cba242a4a63e7c7908963062
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-12-19T06:38:44Z
publishDate 2021-04-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-c2e13b96cba242a4a63e7c79089630622022-12-21T20:32:10ZengBMCBMC Cardiovascular Disorders1471-22612021-04-0121111210.1186/s12872-021-01970-2A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocolEstíbaliz Díaz-Balboa0Violeta González-Salvado1Beatriz Rodríguez-Romero2Amparo Martínez-Monzonís3Milagros Pedreira-Pérez4Patricia Palacios-Ozores5Rafael López-López6Carlos Peña-Gil7José R. González-Juanatey8Cardiology Department, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), University Clinical Hospital of Santiago de Compostela (SERGAS)Cardiology Department, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), University Clinical Hospital of Santiago de Compostela (SERGAS)Psychosocial Intervention and Functional Rehabilitation Research Group, Department of Physiotherapy, Medicine and Biomedical Sciences, Faculty of Physiotherapy, University of A CoruñaCardiology Department, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), University Clinical Hospital of Santiago de Compostela (SERGAS)Cardiology Department, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), University Clinical Hospital of Santiago de Compostela (SERGAS)Health Research Institute of Santiago de Compostela (IDIS)Health Research Institute of Santiago de Compostela (IDIS)Cardiology Department, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), University Clinical Hospital of Santiago de Compostela (SERGAS)Cardiology Department, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), University Clinical Hospital of Santiago de Compostela (SERGAS)Abstract Background Anthracyclines and monoclonal antibodies against human epidermal growth factor receptor-2 (HER2) are frequently used to treat breast cancer but they are associated with risk of developing cardiotoxicity. Implementation of cardioprotective strategies as part of breast cancer treatment are needed. To date, a limited number of studies have examined the effectiveness of cardiac rehabilitation programs or exercise programs in the prevention of cardiotoxicity through an integral assessment of cardiac function. The ONCORE study proposes an exercise-based cardiac rehabilitation program as a non-pharmacological tool for the management of chemotherapy-induced cardiotoxicity. Methods The study protocol describes a prospective, randomized controlled trial aimed to determine whether an intervention through an exercise-based CR program can effectively prevent cardiotoxicity induced by anthracyclines and/or anti-HER2 antibodies in women with breast cancer. Three hundred and forty women with breast cancer at early stages scheduled to receive cardiotoxic chemotherapy will be randomly assigned (1:1) to participation in an exercise-based CR program (intervention group) or to usual care and physical activity recommendation (control group). Primary outcomes include changes in left ventricular ejection fraction and global longitudinal strain as markers of cardiac dysfunction assessed by transthoracic echocardiography. Secondary outcomes comprise levels of cardiovascular biomarkers and cardiopulmonary function through peak oxygen uptake determination, physical performance and psychosocial status. Supervised exercise program-related outcomes including safety, adherence/compliance, expectations and physical exercise in- and out-of-hospital are studied as exploratory outcomes. Transthoracic echocardiography, clinical test and questionnaires will be performed at the beginning and two weeks after completion of chemotherapy. Discussion The growing incidence of breast cancer and the risk of cardiotoxicity derived from cancer treatments demand adjuvant cardioprotective strategies. The proposed study may determine if an exercise-based CR program is effective in minimizing chemotherapy-induced cardiotoxicity in this population of women with early-stage breast cancer. The proposed research question is concrete, with relevant clinical implications, transferable to clinical practice and achievable with low risk. Trial registration ClinicalTrials.gov Identifier: NCT03964142. Registered on 28 May 2019. Retrospectively registered. https://clinicaltrials.gov/ct2/show/NCT03964142https://doi.org/10.1186/s12872-021-01970-2Breast cancerCardiotoxicityCardiac rehabilitationExerciseCardio-oncologyAnthracyclines
spellingShingle Estíbaliz Díaz-Balboa
Violeta González-Salvado
Beatriz Rodríguez-Romero
Amparo Martínez-Monzonís
Milagros Pedreira-Pérez
Patricia Palacios-Ozores
Rafael López-López
Carlos Peña-Gil
José R. González-Juanatey
A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol
BMC Cardiovascular Disorders
Breast cancer
Cardiotoxicity
Cardiac rehabilitation
Exercise
Cardio-oncology
Anthracyclines
title A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol
title_full A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol
title_fullStr A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol
title_full_unstemmed A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol
title_short A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol
title_sort randomized trial to evaluate the impact of exercise based cardiac rehabilitation for the prevention of chemotherapy induced cardiotoxicity in patients with breast cancer oncore study protocol
topic Breast cancer
Cardiotoxicity
Cardiac rehabilitation
Exercise
Cardio-oncology
Anthracyclines
url https://doi.org/10.1186/s12872-021-01970-2
work_keys_str_mv AT estibalizdiazbalboa arandomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT violetagonzalezsalvado arandomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT beatrizrodriguezromero arandomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT amparomartinezmonzonis arandomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT milagrospedreiraperez arandomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT patriciapalaciosozores arandomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT rafaellopezlopez arandomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT carlospenagil arandomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT josergonzalezjuanatey arandomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT estibalizdiazbalboa randomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT violetagonzalezsalvado randomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT beatrizrodriguezromero randomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT amparomartinezmonzonis randomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT milagrospedreiraperez randomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT patriciapalaciosozores randomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT rafaellopezlopez randomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT carlospenagil randomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol
AT josergonzalezjuanatey randomizedtrialtoevaluatetheimpactofexercisebasedcardiacrehabilitationforthepreventionofchemotherapyinducedcardiotoxicityinpatientswithbreastcanceroncorestudyprotocol